Safety and exposure of once-daily ritonavir-boosted atazanavir in HIV-infected pregnant women

Early Postpartum Pharmacokinetics of Lopinavir Initiated Intrapartum in Thai Women

(2009) T. R. Cressey et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Pregnancy and Optimal Care of HIV‐Infected Patients

(2009) Brenna L. Anderson et al.   CLINICAL INFECTIOUS DISEASES

Lopinavir protein binding in HIV-1-infected pregnant women

(2009) FT Aweeka et al.   HIV MEDICINE

Efficacy and Safety of Atazanavir, With or Without Ritonavir, as Part of Once-Daily Highly Active Antiretroviral Therapy Regimens in Antiretroviral-Naive Patients

(2009) D. R (Niel) Malan et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Population analysis of the pregnancy-related modifications in lopinavir pharmacokinetics and their possible consequences for dose adjustment

(2009) M. Bouillon-Pichault et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Lopinavir Exposure With an Increased Dose During Pregnancy

(2008) Mark Mirochnick et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

The steady-state pharmacokinetics of atazanavir/ritonavir in HIV-1-infected adult outpatients is not affected by gender-related co-factors

(2008) N. von Hentig et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY